AdaptHealth Says Linde Gets Restraining Order on Teufel Hiring
By Colin Kellaher
AdaptHealth's new chief executive, Crispin Teufel, won't take the reins until at least October amid efforts by his former employer to block the move.
In a filing with the U.S. Securities and Exchange Commission, AdaptHealth said a U.S. District Court issued a temporary restraining order preventing Teufel from starting his employment with the Plymouth Meeting, Pa., provider of home medical equipment, supplies and related services until Oct. 15.
Linde, Teufel's former employer, last month sued the executive and sought a court order stopping his move to AdaptHealth for an unspecified period while the industrial-gas giant seeks protection of confidential information and trade secrets.
AdaptHealth, which isn't named in the suit, said the court has also scheduled a hearing for Oct. 18.
In the meantime, AdaptHealth said Richard Barasch, who had stepped in as interim CEO on July 1 after the departure of Stephen Griggs, has agreed to remain in the post through Oct. 31.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
August 29, 2023 10:34 ET (14:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn